SAB Biotherapeutics Inc.
SABS | NASDAQ
$3.50
+$0.11 (+3.24%)
Sep 22, 2026, 11:29 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | 114.7K | 114.7K | 377.84K | 1.32M | 1.51M | 2.78M | 2.6M | 2.24M | 4.09M | 6.42M | 12.68M | 23.9M | 32.8M | 43.89M | 55.75M | 60.88M | 75.57M | 60.89M | 42.68M |
Cost of Revenue | 2.28M | 3.1M | 10.01M | 10.03M | 10.23M | 10.43M | 4.76M | 4.92M | 4.94M | 4.81M | 3.75M | 3.72M | 3.65M | 11.34M | 23.74M | 33.47M | 32.97M | 43.07M | 42.52M | 59.78M | 59.37M | 40.69M |
Gross Profit | -2.28M | -3.1M | -10.01M | -9.92M | -10.12M | -10.05M | -3.44M | -3.4M | -2.16M | -2.2M | -1.51M | 370.45K | 2.77M | 1.34M | 161.98K | -665.04K | 10.93M | 12.69M | 18.35M | 15.79M | 1.52M | 1.99M |
Operating Income | -71.82M | -58.18M | -48.95M | -43.19M | -41.82M | -42.29M | -42.91M | -51.78M | -45.79M | -42.06M | -38.08M | -27.06M | -29.55M | -29.61M | -28.92M | -28.4M | -24.58M | -20.91M | -13.39M | 2.53M | 6.52M | 9.4M |
Interest Income | 4.11M | 2.42M | 1.43M | 867.67K | 489.61K | 850.6K | 1.29M | 1.63M | 1.37M | 1.02M | 584.97K | 130.85K | 133.87K | 121.13K | 71.07K | 56.01K | 42.4K | 31.87K | 29.44K | 14.57K | 10.8K | 5.51K |
Pretax Income | -12.78M | -398.43K | 13.27M | 18.74M | -37.06M | -34.28M | -34.11M | -45.57M | -40.32M | -39.87M | -42.19M | -27.19M | -29.16M | -27.15M | -18.72M | -22.42M | -19.4M | -17.48M | -17.14M | 2.85M | 6.91M | 9.85M |
Net Income | -12.78M | -398.43K | 13.27M | 18.74M | -37.06M | -34.28M | -34.11M | -45.57M | -40.32M | -39.87M | -42.19M | -27.21M | -29.19M | -27.08M | -18.74M | -22.42M | -19.4M | -17.57M | -17.14M | 2.85M | 6.91M | 9.85M |
Selling & General & Admin | 21.82M | 17.36M | 14.6M | 11.27M | 10.07M | 9.98M | 9.09M | 22.26M | 22.32M | 21.71M | 22.03M | 9.11M | 9.7M | 11.98M | 14.61M | 20.41M | 20.48M | 18.57M | 16.72M | 9.65M | 6.42M | 4.02M |
Research & Development | 49.22M | 40.05M | 34.33M | 31.23M | 30.11M | 29.92M | 30.39M | 27.05M | 23.24M | 20.08M | 16.47M | 19.31M | 22.62M | 27.56M | 36.38M | 39.88M | 47.59M | 57.68M | 57.14M | 61.8M | 46.77M | 28.09M |
Other Expenses | -1.51M | -2.33M | -9.99M | -9.22M | -8.48M | -7.66M | n/a | -943.62K | -1.93M | -1.93M | -1.93M | -986.16K | n/a | -8.58M | -21.91M | -32.56M | -32.56M | -42.66M | -42.11M | -58.2M | -58.2M | -39.52M |
Operating Expenses | 69.54M | 55.08M | 38.95M | 33.28M | 31.71M | 32.24M | 39.47M | 48.37M | 43.63M | 39.86M | 36.57M | 27.43M | 32.31M | 30.95M | 29.08M | 27.74M | 35.51M | 33.6M | 31.75M | 13.25M | -5.01M | -7.4M |
Interest Expense | 231.5K | 233.84K | 240.66K | 248.08K | 282.82K | 311.6K | 318.4K | 325.41K | 317.07K | 299.27K | 315.28K | 325.1K | 326.03K | 321.95K | 301.58K | 508.34K | 516.28K | 519.47K | 522.64K | 228.18K | 149.63K | 75.19K |
Selling & Marketing Expenses | -730.97K | -730.97K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.17M | -1.17M | -1.17M |
Cost & Expenses | 71.82M | 58.18M | 48.95M | 43.31M | 41.94M | 42.67M | 44.23M | 53.29M | 48.57M | 44.67M | 40.31M | 31.16M | 35.96M | 42.29M | 52.82M | 61.2M | 68.48M | 76.67M | 74.27M | 73.04M | 54.37M | 33.29M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 25.63K | 25.63K | -66.65K | 25.63K | n/a | n/a | 92.28K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 79.75M | 53.56M | 47.61M | 10.66M | 9.29M | 9.29M | 9.26M | 9.26M | 9.26M | 9.24M | 5.93M | 5.24M | 5.04M | 5.04M | 5.04M | 4.3M | 4.3M | 4.31M | 4.35M | 4.35M | 4.35M | 4.35M |
Shares Outstanding (Diluted) | 79.75M | 53.56M | 47.61M | 77.86M | 9.29M | 9.29M | 9.26M | 9.26M | 9.26M | 9.24M | 5.93M | 5.24M | 5.04M | 5.04M | 5.04M | 4.3M | 4.3M | 4.58M | 4.35M | 4.35M | 4.35M | 4.35M |
EPS (Basic) | 3.57 | 2.76 | 2.55 | 1.38 | -4 | -3.70 | -3.68 | -6.31 | -6.16 | -6.73 | -7.65 | -5.35 | -5.98 | -5.73 | -4.04 | -6.59 | -5.07 | -4.64 | -4.54 | 8.04 | 8.11 | 8.79 |
EPS (Diluted) | -0.86 | -1.67 | -1.88 | -2.30 | -4 | -3.70 | -3.68 | -6.31 | -6.16 | -6.73 | -7.65 | -5.35 | -5.98 | -5.73 | -4.05 | -6.60 | -5.07 | -4.65 | -4.54 | 8.04 | 8.11 | 8.79 |
EBITDA | -9.46M | 2.94M | 16.64M | 22.14M | -33.42M | -30.41M | -29.03M | -40.32M | -35.07M | -34.76M | -38.13M | -23.14M | -25.18M | -23.32M | -15.15M | -18.95M | -16.43M | -14.99M | -15.06M | 4.32M | 7.9M | 10.5M |
EBIT | -12.54M | -164.59K | 13.51M | 18.99M | -36.77M | -33.96M | -33.79M | -45.24M | -40M | -39.57M | -41.88M | -26.86M | -28.83M | -26.83M | -18.41M | -21.91M | -18.89M | -16.96M | -16.62M | 3.22M | 7.2M | 10.07M |
Depreciation & Amortization | 3.08M | 3.1M | 3.13M | 3.15M | 3.35M | 3.55M | 4.76M | 4.92M | 4.94M | 4.81M | 3.75M | 3.72M | 3.65M | 3.51M | 3.26M | 2.96M | 2.46M | 1.97M | 1.57M | 1.11M | 695.36K | 436.47K |
Add to Watchlist
Select watchlists to add or remove SABS